RegeneRx Biopharmaceuticals, Inc.

OTCPK:RGRX Stock Report

Market Cap: US$2.1k

RegeneRx Biopharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of RGRX?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders99,9956.63%
Public Companies195,83313%
Private Companies364,89124.2%
General Public847,87256.2%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 7 shareholders own 43.8% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
23.2%
Alfasigma S.p.A.
349,891US$489.80%no data
13%
HLB Therapeutics Co.,Ltd.
195,833US$274.20%no data
4.32%
Joseph McNay
65,241US$91.30%no data
1.17%
J. Finkelstein
17,694US$24.80%no data
1.06%
Allan Goldstein
16,015US$22.40%no data
0.99%
Aptafin S.p.A.
15,000US$21.00%no data
0.069%
R. Elsey
1,045US$1.50%no data